Contact
Sitemap
Download PDF
Print
Integrated
Annual Report
Home
DSM at a glance
Key data for 2010
Key data
Letter from the Chairman
DSM in motion: driving focused growth
Report by the Managing Board
Highlights of 2010
Vision 2010
Sustainability strategy
People in 2010
Planet in 2010
Profit in 2010
Outlook
Financial policy
Innovation
External recognition
Review of business
Life Sciences
Nutrition
Pharma
Materials Sciences
Performance Materials
Polymer Intermediates
Other activities
Corporate governance and risk management
Introduction
Dutch corporate governance code
Governance framework
Risk management
Statements of the Managing Board
Report by the Supervisory Board
Supervisory Board report
Remuneration policy regarding the Managing Board and the Supervisory Board
Supervisory Board and Managing Board
What still went wrong
Information about the DSM share
Consolidated financial statements
Summary of significant accounting policies
Consolidated statements
Notes to the consolidated financial statements of Royal DSM N.V.
Financial statements of Royal DSM N.V.
Notes to the Royal DSM N.V. financial statements
Other information
Independent Assurance Report on People and Planet
Independent Auditor's Report on the Financial Statements
Profit appropriation
Special statutory rights
DSM figures: five-year summary
Sustainability reporting approach
Explanation of some concepts and ratios
Downloads
You are here:
Home
>
Review of business
> Life Sciences
Previous -
Review of business
Next -
Nutrition
Life Sciences
DSM's Life Sciences activities are bundled into
two clusters: Nutrition and Pharma. In 2010,
both clusters represented 46% of DSM's net
sales from continuing operations.
usage menu
Previous -
Review of business
Next -
Nutrition
Sitemap
User Terms and Conditions
Privacy and Cookie Statement
User Terms and Conditions Annual report